Zura Bio (ZURA) Net Cash Flow (2022 - 2026)

Zura Bio's Net Cash Flow history runs 5 years deep, the most recent figure standing at $116.2 million for Q1 2026.

• On a quarterly basis, Net Cash Flow rose 2059.64% year-over-year to $116.2 million in Q1 2026; TTM through Mar 2026 was $55.0 million, a 324.58% increase from a year earlier, with the FY2025 full-year figure at -$67.1 million, down 187.48% from the prior year.
• Net Cash Flow grew to $116.2 million in Q1 2026 per ZURA's latest filing, from -$29.6 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $116.2 million in Q1 2026 and bottomed at -$29.6 million in Q4 2025.
• The 5-year median for Net Cash Flow is -$4.1 million (2023), against an average of $7.4 million.
• Across the five-year window, Net Cash Flow surged 24317.21% in 2023 and slumped 6869.82% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at -$1.5 million in 2022, then slumped by 173.48% to -$4.1 million in 2023, then plunged by 189.24% to -$11.7 million in 2024, then slumped by 152.58% to -$29.6 million in 2025, then soared by 492.39% to $116.2 million in 2026.
• Per Business Quant, the three latest ZURA Net Cash Flow figures stand at $116.2 million (Q1 2026), -$29.6 million (Q4 2025), and -$15.5 million (Q3 2025).